Kolexia
Molina Jean-Michel Maladies infectieuses
Molina Jean-Michel
Maladies infectieuses
Hôpital Saint-Louis
Paris, France
706 Activités
2.3 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH Syndrome d'immunodéficience acquise Hépatite Maladies transmissibles Co-infection Hépatite C Hépatite C chronique Tuberculose Maladies sexuellement transmissibles

Collaborateurs

Voir plus
Delaugerre Constance
Delaugerre Constance
Hôpital Saint-Louis, Paris, France
Raffi Francois
Raffi Francois
Hôpital Hôtel-Dieu Nantes, Nantes, France
Katlama Christine
Katlama Christine
Hôpital Pitie Salpetriere, Paris, France
De Castro Nathalie
De Castro Nathalie
Hôpital Saint-Louis, Paris, France

Industries

Voir plus
MSD
40 collaboration(s)
Dernière en 2023
Gilead
27 collaboration(s)
Dernière en 2023
ViiV Healthcare
24 collaboration(s)
Dernière en 2023
Edimark
4 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Étude ANRS 174 Doxyvac : analyse des principaux résultats
Edimark   01 mars 2024
START: Strategic Timing of AntiRetroviral Treatment
Essai Clinique (BMS)   29 février 2024
CAPELLA: A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS-6207 in Combination With an Optimized Background Regimen in Heavily Treatment Experienced People Living With HIV-1 Infection With Multidrug Resistance
Essai Clinique (Gilead)   23 février 2024
DRIVE-FORWARD: A Phase 3 Multicenter, Double-Blind, Randomized, Active Comparator-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Doravirine (MK-1439) 100 mg Once Daily Versus Darunavir 800 mg Once Daily Plus Ritonavir 100 mg Once Daily, Each in Combination With TRUVADA™ or EPZICOM™/KIVEXA™, in Treatment-Naïve HIV-1 Infected Subjects
Essai Clinique (Merck & Co.)   22 février 2024
CABOPrEP: Impact of Long-acting Injectable Cabotegravir for HIV Pre-exposure Prophylaxis Persistence and Coverage in Men Who Have Sex With Men in France: a Randomized Controlled Clinical Trial.
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   21 février 2024
Failure of bamlanivimab with selection of E484K mutation in an allogeneic stem cell transplant recipient with nosocomial SARS-CoV-2 infection.
Antiviral therapy   15 février 2024
Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapy: 96-week pooled analysis.
AIDS (London, England)   12 février 2024
Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients: A Multi-arm, Phase 3, Randomized, Placebo Controlled, Double Blind Clinical Trial to Investigate the Efficacy and Safety of Fostemsavir (BMS-663068/GSK3684934) in Heavily Treatment Experienced Subjects Infected With Multi-drug Resistant HIV-1 (BRIGHTE Study)
Essai Clinique (ViiV Healthcare)   29 janvier 2024
Isisekelo Sempilo Trial to Optimize Peer (Thetha Nami) Delivery of HIV Prevention to Young People in Rural KwaZulu-Natal: Isisekelo Sempilo: HIV Prevention Embedded in Sexual Health: A Pilot Trial to Optimize Peer (Thetha Nami) Delivery of HIV Prevention and Care to Adolescents and Young Adults in Rural KwaZulu-Natal.
Essai Clinique (Africa Health Research Institute)   29 décembre 2023
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials.
The lancet. HIV   20 décembre 2023